Health Insurance Law Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Health Insurance Law Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
PrimeCell Therapeutics
PrimeCell Therapeutics taps Preston Gates to inform lawmakers about adult stem cell science
August 13th, 2006
PrimeCell Therapeutics LLC has expanded its relationship with Preston Gates & Ellis LLP to inform members of Congress and the Bush administration about recent breakthroughs that overcome the technical and ethical hurdles facing both adult and embryonic stem cells. Preston Gates is the company's intellectual property and biotech business counsel. Company officials recently met with members of Congress on the issue of stem cell research to share promising new advances in a third category of stem cells defined by the President's Council on Bioethics white paper, Alternative Sources of Human Pluripotent Stem Cells - adult stem cells that can be...
Source: Health Insurance Law Weekly (2006-08-13)
|
